Expert narratives in cardiovascular disease and antihyperglycemic therapy
(CEM 237 EN)
Title : Expert narratives in cardiovascular disease and antihyperglycemic therapy
Format : Interactive conference
Time : 1h to 1.5h of Category 1 credits
Beginning : december 2019
Validation and credit : 1h to 1.5h of Category 1 credits to the participants in this activity
Collaboration : This program has received an educational grant and in-kind support from Eli Lilly
Learning objectives:
Upon completion of this program, participants will be better able to:
- Discuss the practical application of screening patients with T2DM for CV risk factors
- Describe how the patient populations in the antihyperglycemic cardiovascular outcome trials differ from one another and the clinical significance of these differences
- Develop a cardioprotective treatment plan for patients with T2DM and established CVD as well as those with no prior CVD based on that patient's age and CV risk factors
Comité scientifique :
- Alice Y. Y. Cheng, M.D., FRCPC , Toronto (Ontario)
- Jeffrey Habert, M.D., CCMF, FCMF , Toronto (Ontario)
- Johanne Desforges, M.D., Montréal (Québec)
- James Kim, MB, BCh, Calgary (Alberta)
- Lionel Noronha, M.D., CCFP, FCFP, Stirling (Ontario)
- Jean-François Yale, M.D., CSPQ, FRCPC, Montréal (Québec)
Renseignements : Direction de la Formation professionnelle de la FMOQ. 514 878-1911 ou au 1 800 361-8499, dfp@fmoq.org
